NYSE: ECVTEcovyst Inc Stock
$7.76-0.09 (-1.15%)
Updated Jan 24, 2025
ECVT Price
$7.76
Fair Value Price
N/A
Market Cap
$904.12M
52 Week Low
$6.02
52 Week High
$11.35
P/E
17.24x
P/B
1.24x
P/S
1.15x
PEG
0.33x
Dividend Yield
N/A
Revenue
$695.34M
Earnings
$53.70M
Gross Margin
28%
Operating Margin
15.41%
Profit Margin
7.7%
Debt to Equity
1.52
Operating Cash Flow
$171M
Beta
1.05
Next Earnings
Feb 26, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ECVT Overview
Ecovyst Inc. manufactures specialty inorganic performance chemicals, specialty catalysts, and specialty glass materials. Known as PQ Group Holdings Inc. until 2021/08, Ecovyst Inc. was founded in 1831 and is headquartered in Malvern, PA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ECVT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Value
C
Growth
D
Momentum
D
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
B
ECVT
Ranked#24 of 53
Ranked#24 of 53
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.92 | A | |
| $497.22 | A | |
| $42.71 | A |
Be the first to know about important ECVT news, forecast changes, insider trades & much more!
ECVT News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ECVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ECVT ($7.76) is trading below its intrinsic value of $10.12, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ECVT is good value based on its earnings relative to its share price (17.24x), compared to the US market average (30.33x)
P/E vs Market Valuation
ECVT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ECVT due diligence checks available for Premium users.
Valuation
ECVT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.24x
Industry
29.84x
Market
30.33x
ECVT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ECVT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ECVT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.24x
Industry
3.32x
ECVT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ECVT price to earnings growth (PEG)
For valuing profitable companies with growth potential
ECVT is good value based... subscribe to Premium to read more.
PEG Value Valuation
ECVT's financial health
Profit margin
Revenue
$179.2M
Net Income
$14.3M
Profit Margin
8%
ECVT's Earnings (EBIT) of $107.14M... subscribe to Premium to read more.
Interest Coverage Financials
ECVT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.8B
Liabilities
$1.1B
Debt to equity
1.52
ECVT's short-term assets ($283.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ECVT's long-term liabilities ($998.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ECVT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ECVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$59.9M
Investing
-$19.4M
Financing
-$764.0k
ECVT's operating cash flow ($170.59M)... subscribe to Premium to read more.
Debt Coverage Financials
ECVT vs Specialty Chemical Stocks
Ecovyst Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.